tetramethylpyrazine has been researched along with monocrotaline in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors | Studies |
---|---|
Cui, S; Ding, W; Wang, B; Yang, B; Zhou, C | 1 |
Black, SM; Chen, J; Chen, X; Chen, Y; Desai, AA; Duan, X; Garcia, JGN; He, W; Hong, C; Hou, C; Kuang, M; Li, M; Liao, J; Liu, C; Liu, S; Lu, W; Makino, A; Rischard, F; Tang, H; Vanderpool, RR; Wang, J; Wu, X; Yang, K; Yuan, JX; Zhang, J; Zhang, N; Zhang, Z; Zheng, Q; Zhong, N; Zou, G | 1 |
Bai, YZ; Cao, YQ; Dong, WP; Dong, Z; Liu, Y; Ma, XM; Wang, XW; Yang, B; Yang, DP; Yang, YC; Zeng, YY | 1 |
3 other study(ies) available for tetramethylpyrazine and monocrotaline
Article | Year |
---|---|
[Observation of relationship between function and structure of experimental pulmonary artery hypertension in rats and inhibitory effect of garlicin and other herbal medicines].
Topics: Alkaloids; Allyl Compounds; Animals; Antihypertensive Agents; Benzylisoquinolines; Blood Pressure; Disulfides; Hypertension, Pulmonary; Male; Monocrotaline; Pulmonary Artery; Pyrazines; Random Allocation; Rats; Rats, Wistar; Vasodilator Agents | 1996 |
Tetramethylpyrazine: A promising drug for the treatment of pulmonary hypertension.
Topics: Animals; Cell Proliferation; Disease Models, Animal; Humans; Hypertension, Pulmonary; Monocrotaline; Myocytes, Smooth Muscle; Pharmaceutical Preparations; Pulmonary Artery; Pyrazines; Rats; Rats, Sprague-Dawley | 2020 |
Tetramethylpyrazine Improves Monocrotaline-Induced Pulmonary Hypertension through the ROS/iNOS/PKG-1 Axis.
Topics: Animals; Hypertension, Pulmonary; Monocrotaline; Nitric Oxide Synthase Type II; Protein Kinases; Pyrazines; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2022 |